New Generation Sequencing of Targeted Genes in the Classical and the Variant Form of Hairy Cell Leukemia Highlights Mutations in Epigenetic Regulation Genes
Overview
Authors
Affiliations
Classical hairy cell leukemia (HCL-c) is a rare lymphoid neoplasm. mutation, detected in more than 80% of the cases, is described as a driver mutation, but additional genetic abnormalities appear to be necessary for the disease progression. For cases of HCL-c harboring a wild-type gene, the differential diagnosis of the variant form of HCL (HCL-v) or splenic diffuse red pulp lymphoma (SDRPL) is complex. We selected a panel of 21 relevant genes based on a literature review of whole exome sequencing studies (, , , , , , , , , , , , , , , , , , , , and ). We analyzed 20 HCL-c and 4 HCL-v patients. The analysis of diagnostic samples mutations in ( = 18), ( = 4), ( = 3), ( = 2), ( = 2), ( = 2), ( = 2) ( = 1) and ( = 1). was found in 90% (18/20) of HCL-c patients. In HCL-c patients with , other mutations were found in 33% (6/18) of cases. All 4 HCL-v patients had mutations in epigenetic regulatory genes: ( = 2), ( = 1) or ( = 1). The analysis of sequential samples (at diagnosis and relapse) from 5 patients (2 HCL-c and 3 HCL-v), showed the presence of 2 new subclonal mutations ( and ) in one patient and variations of the mutated allele frequency in 2 other cases. In the HCL-v disease, we described new mutations targeting that encode a lysine demethylase protein. This opens new perspectives for personalized medicine for this group of patients.
Carullo G, Rossi S, Giudice V, Pezzotta A, Chianese U, Scala P ACS Pharmacol Transl Sci. 2024; 7(7):2125-2142.
PMID: 39022363 PMC: 11249625. DOI: 10.1021/acsptsci.4c00208.
Paillassa J, Maitre E, Belarbi Boudjerra N, Madani A, Benlakhal R, Matthes T Cancers (Basel). 2024; 16(12).
PMID: 38927891 PMC: 11201647. DOI: 10.3390/cancers16122185.
Yap J, Yuan J, Ng W, Chen G, Sim Y, Goh K Mol Cancer. 2023; 22(1):125.
PMID: 37543582 PMC: 10403926. DOI: 10.1186/s12943-023-01817-8.
Hairy cell leukaemia with unusual BRAF mutations.
Maitre E, Macro M, Troussard X J Cell Mol Med. 2023; 27(17):2626-2630.
PMID: 37530550 PMC: 10468650. DOI: 10.1111/jcmm.17890.
Hairy Cell Leukemia: Where Are We in 2023?.
Mendez-Hernandez A, Moturi K, Hanson V, Andritsos L Curr Oncol Rep. 2023; 25(8):833-840.
PMID: 37097545 PMC: 10126561. DOI: 10.1007/s11912-023-01419-z.